DVHA’s Preferred Drug List (PDL) includes a list of preferred and non-preferred drugs.
The PDL is designed to manage the state’s cost of providing prescription drugs while assuring broad access to clinically appropriate and cost-effective therapy. Both clinical and cost considerations determine PDL placement.
Measuring how often providers are prescribing a preferred medication versus a non-preferred medication that requires a Prior Authorization (PA), allows DVHA to target and educate low compliance prescribers to improve compliance rates and lower DVHA’s net costs.
Last updated: 07/15/2020